Atlas Trials

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

Clinical trial NCT06577090 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06577090
Sponsor
Skye Bioscience, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2024-08-22
Primary completion
2026-11-20
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.